ClinicalTrials.gg
DrugBiological

Romiplostim clinical trials

Also written Nplate, AMG 531 and GNR-069.

studies test it
90
open now
28
in phase 3
25
first study started
2002

How each study uses romiplostim is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the romiplostim studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
22 Aug 2008 · NPLATE · BLA 125268 (FDA, Drugs@FDA)
European Union
4 Feb 2009 · Nplate · EMEA/H/C/000942 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Romiplostim
58
Romiplostim N01
18
Romiplostim (AMG-531)
2
TPO-RA
2
Amgen megakaryopoiesis protein 2
2

Brand

Nplate
23

Development codes

AMG 531
21
GNR-069
2
GP404141
1
GP40141
1

Studies by the year they started

90 studies that test it; most in 2026 (13)

Studies that test romiplostim, by start year
YearStudies
20022
20041
20055
20068
20072
20081
20093
20102
20111
20121
20132
20145
20155
20162
20181
20194
20208
20211
20224
20233
20246
202510
202613

By phase

A phase 1/2 study counts in both.

Early Phase 1
2
Phase 1
10
Phase 2
54
Phase 3
25
Phase 4
5
No phase
5

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 38 · Other 52

Amgen (25) · Peking Union Medical College Hospital (6) · Kyowa Kirin Co., Ltd. (5) · Memorial Sloan Kettering Cancer Center (4) · The First Affiliated Hospital of Soochow University (3) · Geropharm (2) · Anjali Sharathkumar (2) · AO GENERIUM (2)

Often tested with

Tested in the same studies.

Eltrombopag (3) · Rituximab (3) · Dexamethasone (2) · Cyclosporine (2) · Thrombopoietin Receptor Agonist (1) · Adrenal Cortex Hormones (1) · Immunoglobulins (1) · Prednisolone (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 7

Studies that test romiplostim.

Studies

Open first, then newest update. How each study uses romiplostim is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 90

See all 90 studies that test romiplostim →

Given beside what is tested · 5 — romiplostim is usual care or a partner of the new treatment

What changed recently

From the registry's own updates since Oct 18, 2026.

Codes

What other systems call romiplostim · ClinicalTrials.gg INT004684

  • MeSH (NLM) C488777romiplostimOne source NLM
  • UNII (FDA) GN5XU2DXKVROMIPLOSTIMConfirmed FDA, NLM, Wikidata
  • RxNorm 805452Confirmed FDA, Wikidata
  • Wikidata Q1235195romiplostimConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C52183RomiplostimConfirmed FDA, Wikidata
  • DrugBank DB05332One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.